ArticleCirculation2013
Stem cells and myocardial regeneration: cooperation wins over competition.
Article in Circulation, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- Competitive signaling and cellular communications in myocardial infarction response.Molecular biology reports · 2025Review
- Competitive signaling and cellular communications in myocardial infarction response.Molecular biology reports · 2025Review
- Strategies to develop endogenous stem cell-recruiting bioactive materials for tissue repair and regeneration.Advanced drug delivery reviews · 2017Review
- Exploring pericyte and cardiac stem cell secretome unveils new tactics for drug discovery.Pharmacology & therapeutics · 2017Review
- Rebuilding the Damaged Heart: Mesenchymal Stem Cells, Cell-Based Therapy, and Engineered Heart Tissue.Physiological reviews · 2016Review
- Stem cell therapy for heart failure: Ensuring regenerative proficiency.Trends in cardiovascular medicine · 2016Review
- Ghrelin improves functional survival of engrafted adipose-derived mesenchymal stem cells in ischemic heart through PI3K/Akt signaling pathway.BioMed research international · 2015Article
- Comparison of Cardiomyocyte Differentiation Potential Between Type 1 Diabetic Donor- and Nondiabetic Donor-Derived Induced Pluripotent Stem Cells.Cell transplantation · 2015Article
- Cardiac stem cells: biology and clinical applications.Antioxidants & redox signaling · 2014Review
- Cardiac stem cell niches.Stem cell research · 2014Review
- Recruitment and retention of human autologous CD34+ CD117+ CD133+ bone marrow stem cells to infarcted myocardium followed by directed vasculogenesis: Novel strategy for cardiac regeneration.Molecular and cellular therapies · 2013Article
- The advancing field of cell-based therapy: insights and lessons from clinical trials.Journal of the American Heart Association · 2013Review
- Durable scar size reduction due to allogeneic mesenchymal stem cell therapy regulates whole-chamber remodeling.Journal of the American Heart Association · 2013Article
- Induced pluripotent stem cells: how they will change the practice of cardiovascular medicine.Methodist DeBakey cardiovascular journalReview
- The existence of myocardial repair: mechanistic insights and enhancements.Cardiology in reviewReview
Corrections and comments
- Correction · 2015-11-30Conflict of Interest · Error in Text · · P Anversa otherwise investigated;
- Comment on
- Erratum issuedCorrection.2015
Authors and funding
2 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.